Inflammation in cancer and depression: a starring role for the kynurenine pathway
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inflammation in cancer and depression: a starring role for the kynurenine pathway
Authors
Keywords
Cancer, Chemotherapy, Depression, IDO inhibitors, Immunotherapy, Inflammation, Indoleamine 2-3-dioxygenase, Kynurenine
Journal
PSYCHOPHARMACOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2019-02-26
DOI
10.1007/s00213-019-05200-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genetic alterations affecting the genes encoding the enzymes of the kynurenine pathway and their association with human diseases
- (2018) Fanni A. Boros et al. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
- Reversal of indoleamine 2,3-dioxygenase–mediated cancer immune suppression by systemic kynurenine depletion with a therapeutic enzyme
- (2018) Todd A Triplett et al. NATURE BIOTECHNOLOGY
- Kynurenine pathway in depression: A systematic review and meta-analysis
- (2018) Kamiyu Ogyu et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Role of Kynurenine Pathway and its Metabolites in Mood Disorders: A Systematic Review and Meta-Analysis of Clinical Studies
- (2018) Danilo Arnone et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Understanding the Pathophysiology of Psychological Distress and Pancreatic Cancer
- (2018) Travis M. Bettison et al. PANCREAS
- A prospective evaluation of serum kynurenine metabolites and risk of pancreatic cancer
- (2018) Joyce Y. Huang et al. PLoS One
- A promising new cancer drug has hit a major setback, raising questions about whether the field is moving too fast
- (2018) Ken Garber SCIENCE
- Discovery of indoleamine 2,3-dioxygenase inhibitors using machine learning based virtual screening
- (2018) Hongao Zhang et al. MedChemComm
- Neuroimmunology of Behavioral Comorbidities Associated With Cancer and Cancer Treatments
- (2018) Jessica C. Santos et al. Frontiers in Immunology
- Use of PD-1 Targeting, Macrophage Infiltration, and IDO Pathway Activation in Sarcomas
- (2018) Maud Toulmonde et al. JAMA Oncology
- A Role for Tryptophan-2,3-dioxygenase in CD8 T Cell Suppression and Evidence of Tryptophan Catabolism in Breast Cancer Patient Plasma
- (2018) Lisa I Greene et al. MOLECULAR CANCER RESEARCH
- Pancreatic Cancer–Associated Depression
- (2018) Adam F. Barnes et al. PANCREAS
- Inhibiting IDO pathways to treat cancer: lessons from the ECHO-301 trial and beyond
- (2018) Alexander J. Muller et al. Seminars in Immunopathology
- Persistent fatigue induced by interferon-alpha: a novel, inflammation-based, proxy model of chronic fatigue syndrome
- (2018) Alice Russell et al. PSYCHONEUROENDOCRINOLOGY
- The risk of being depressed is significantly higher in cancer patients than in the general population: Prevalence and severity of depressive symptoms across major cancer types
- (2017) T.J. Hartung et al. EUROPEAN JOURNAL OF CANCER
- Combinatorial antitumor effects of indoleamine 2,3-dioxygenase inhibitor NLG919 and paclitaxel in a murine B16-F10 melanoma model
- (2017) Xiangjing Meng et al. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
- Associations Between Neurotransmitter Genes and Fatigue and Energy Levels in Women After Breast Cancer Surgery
- (2017) Jasmine Eshragh et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- Sleep disturbance and kynurenine metabolism in depression
- (2017) Hyong Jin Cho et al. JOURNAL OF PSYCHOSOMATIC RESEARCH
- Annual Report to the Nation on the Status of Cancer, 1975–2014, Featuring Survival
- (2017) Ahmedin Jemal et al. JNCI-Journal of the National Cancer Institute
- Stress-related regulation of the kynurenine pathway: Relevance to neuropsychiatric and degenerative disorders
- (2017) Katherine O'Farrell et al. NEUROPHARMACOLOGY
- Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinoma
- (2017) Giuseppe Lucarelli et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- P53 prevent tumor invasion and metastasis by down-regulating IDO in lung cancer
- (2017) Dongfang Tang et al. Oncotarget
- Annual Report to the Nation on the Status of Cancer, 1975–2014, Featuring Survival
- (2017) Ahmedin Jemal et al. JNCI-Journal of the National Cancer Institute
- PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome
- (2017) Hashem O. Alsaab et al. Frontiers in Pharmacology
- Revisiting the tryptophan-serotonin deficiency and the inflammatory hypotheses of major depression in a biopsychosocial approach
- (2017) Andreas Baranyi et al. PeerJ
- Altered KYN/TRP, Gln/Glu, and Met/methionine sulfoxide ratios in the blood plasma of medication-free patients with major depressive disorder
- (2017) Hidehiro Umehara et al. Scientific Reports
- Plasma Biomarkers of Inflammation, the Kynurenine Pathway, and Risks of All-Cause, Cancer, and Cardiovascular Disease Mortality
- (2016) Hui Zuo et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorder
- (2016) Timothy B. Meier et al. BRAIN BEHAVIOR AND IMMUNITY
- Aberrant Kynurenine Signaling Modulates DNA Replication Stress Factors and Promotes Genomic Instability in Gliomas
- (2016) April C. L. Bostian et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Stress, the Autonomic Nervous System, and the Immune-kynurenine Pathway in the Etiology of Depression
- (2016) Eunsoo Won et al. Current Neuropharmacology
- Cytokine-mediated blood brain barrier disruption as a conduit for cancer/chemotherapy-associated neurotoxicity and cognitive dysfunction
- (2016) Hannah R. Wardill et al. INTERNATIONAL JOURNAL OF CANCER
- IDO2 Modulates T Cell–Dependent Autoimmune Responses through a B Cell–Intrinsic Mechanism
- (2016) Lauren M. F. Merlo et al. JOURNAL OF IMMUNOLOGY
- Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015
- (2016) Haidong Wang et al. LANCET
- Transcriptomics in Interferon-α-Treated Patients Identifies Inflammation-, Neuroplasticity- and Oxidative Stress-Related Signatures as Predictors and Correlates of Depression
- (2016) Nilay Hepgul et al. NEUROPSYCHOPHARMACOLOGY
- Interferon-alpha-induced inflammation is associated with reduced glucocorticoid negative feedback sensitivity and depression in patients with hepatitis C virus
- (2016) Jennifer C. Felger et al. PHYSIOLOGY & BEHAVIOR
- Role of neuro-immunological factors in the pathophysiology of mood disorders
- (2016) Anindya Bhattacharya et al. PSYCHOPHARMACOLOGY
- Therapeutic targeting of inflammation and tryptophan metabolism in colon and gastrointestinal cancer
- (2016) Srikanth Santhanam et al. Translational Research
- IDO in the Tumor Microenvironment: Inflammation, Counter-Regulation, and Tolerance
- (2016) David H. Munn et al. TRENDS IN IMMUNOLOGY
- PD-L1 expression in human cancers and its association with clinical outcomes
- (2016) Jinming Yu et al. OncoTargets and Therapy
- Cancer and inflammation
- (2016) Lance L. Munn Wiley Interdisciplinary Reviews-Systems Biology and Medicine
- Lung cancer-derived galectin-1 contributes to cancer associated fibroblast-mediated cancer progression and immune suppression through TDO2/kynurenine axis
- (2016) Ya-Ling Hsu et al. Oncotarget
- Inhibiting tryptophan metabolism enhances interferon therapy in kidney cancer
- (2016) Josephine F. Trott et al. Oncotarget
- Dietary tryptophan depletion in humans using a simplified two amino acid formula – a pilot study
- (2016) Maike Linden et al. Food & Nutrition Research
- Interferon-alpha treatment induces depression-like behaviour accompanied by elevated hippocampal quinolinic acid levels in rats
- (2015) Christina Weide Fischer et al. BEHAVIOURAL BRAIN RESEARCH
- Reduction of kynurenic acid to quinolinic acid ratio in both the depressed and remitted phases of major depressive disorder
- (2015) Jonathan Savitz et al. BRAIN BEHAVIOR AND IMMUNITY
- Inflammation-induced activation of the indoleamine 2,3-dioxygenase pathway: Relevance to cancer-related fatigue
- (2015) Sangmi Kim et al. CANCER
- The potential of targeting indoleamine 2,3-dioxygenase for cancer treatment
- (2015) Johanna M Gostner et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Kynurenine pathway dysfunction in the pathophysiology and treatment of depression: Evidences from animal and human studies
- (2015) Gislaine Z. Réus et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Cancer-Related Fatigue, Version 2.2015
- (2015) Ann M. Berger et al. Journal of the National Comprehensive Cancer Network
- Fluoxetine prevents the development of depressive-like behavior in a mouse model of cancer related fatigue
- (2015) Diana M. Norden et al. PHYSIOLOGY & BEHAVIOR
- Posttraumatic stress and depressive symptoms in renal cell carcinoma: association with quality of life and utility of single-item distress screening
- (2015) Seema Malhotra Thekdi et al. PSYCHO-ONCOLOGY
- Ongoing episode of major depressive disorder is not associated with elevated plasma levels of kynurenine pathway markers
- (2015) Johan Dahl et al. PSYCHONEUROENDOCRINOLOGY
- Levels in neurotransmitter precursor amino acids correlate with mental health in patients with breast cancer
- (2015) K. Hüfner et al. PSYCHONEUROENDOCRINOLOGY
- Activation of the kynurenine pathway is associated with striatal volume in major depressive disorder
- (2015) Jonathan Savitz et al. PSYCHONEUROENDOCRINOLOGY
- Effects of psychotropic drugs on inflammation: consequence or mediator of therapeutic effects in psychiatric treatment?
- (2015) David Baumeister et al. PSYCHOPHARMACOLOGY
- Low-grade inflammation predicts persistence of depressive symptoms
- (2015) A. Zalli et al. PSYCHOPHARMACOLOGY
- The biology of cancer-related fatigue: a review of the literature
- (2015) Leorey N. Saligan et al. SUPPORTIVE CARE IN CANCER
- Inflammation and neuronal plasticity: a link between childhood trauma and depression pathogenesis
- (2015) Annamaria Cattaneo et al. Frontiers in Cellular Neuroscience
- Neuroinflammation and Depression: Microglia Activation, Extracellular Microvesicles and microRNA Dysregulation
- (2015) Dora Brites et al. Frontiers in Cellular Neuroscience
- Understanding the role of the kynurenine pathway in human breast cancer immunobiology
- (2015) Benjamin Heng et al. Oncotarget
- Affective Symptoms and White Matter Changes in Brain Tumor Patients
- (2015) Andre Richter et al. World Neurosurgery
- Imaging cerebral tryptophan metabolism in brain tumor-associated depression
- (2015) Edit Bosnyák et al. EJNMMI Research
- Comprehensive Meta-Analysis of Excess Mortality in Depression in the General Community Versus Patients With Specific Illnesses
- (2014) Pim Cuijpers et al. AMERICAN JOURNAL OF PSYCHIATRY
- Melanoma tumors alter proinflammatory cytokine production and monoamine brain function, and induce depressive-like behavior in male mice
- (2014) Andrea Lebeña et al. BEHAVIOURAL BRAIN RESEARCH
- IDO2 is critical for IDO1-mediated T-cell regulation and exerts a non-redundant function in inflammation
- (2014) Richard Metz et al. INTERNATIONAL IMMUNOLOGY
- Indoleamine 2,3-Dioxygenase 1 (IDO1) Is Up-Regulated in Thyroid Carcinoma and Drives the Development of an Immunosuppressant Tumor Microenvironment
- (2014) Sonia Moretti et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Benzofuranquinones as inhibitors of indoleamine 2,3-dioxygenase (IDO). Synthesis and biological evaluation
- (2014) Catarina Carvalho et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Involvement of the Kynurenine Pathway in Human Glioma Pathophysiology
- (2014) Seray Adams et al. PLoS One
- A Review of the Clinical, Economic, and Societal Burden of Treatment-Resistant Depression: 1996–2013
- (2014) David A. Mrazek et al. PSYCHIATRIC SERVICES
- Does tryptophan degradation along the kynurenine pathway mediate the association between pro-inflammatory immune activity and depressive symptoms?
- (2014) Jacqueline Quak et al. PSYCHONEUROENDOCRINOLOGY
- IDO is highly expressed in breast cancer and breast cancer-derived circulating microvesicles and associated to aggressive types of tumors by in silico analysis
- (2014) M. T. Isla Larrain et al. TUMOR BIOLOGY
- Chemotherapy-enhanced inflammation may lead to the failure of therapy and metastasis
- (2014) Dinesh Vyas et al. OncoTargets and Therapy
- A biological basis for depression in pancreatic cancer
- (2014) Isadora C. Botwinick et al. HPB
- Depression and anxiety in prostate cancer: a systematic review and meta-analysis of prevalence rates
- (2014) Sam Watts et al. BMJ Open
- Trial watch: IDO inhibitors in cancer therapy
- (2014) Erika Vacchelli et al. OncoImmunology
- C-reactive protein predicts fatigue independently of depression in breast cancer patients prior to chemotherapy
- (2013) Maria M. Pertl et al. BRAIN BEHAVIOR AND IMMUNITY
- Hippocampal dysfunctions in tumor-bearing mice
- (2013) Miyoung Yang et al. BRAIN BEHAVIOR AND IMMUNITY
- Serotonin – Kynurenine Hypothesis of Depression: Historical Overview and Recent Developments
- (2013) Gregory Oxenkrug CURRENT DRUG TARGETS
- Depression, cytokines, and pancreatic cancer
- (2013) William Breitbart et al. PSYCHO-ONCOLOGY
- Prevalence of depression in cancer patients: a meta-analysis of diagnostic interviews and self-report instruments
- (2013) A. M. H. Krebber et al. PSYCHO-ONCOLOGY
- Depressive symptoms are a risk factor for all-cause mortality: results from a prospective population-based study among 3,080 cancer survivors from the PROFILES registry
- (2013) Floortje Mols et al. Journal of Cancer Survivorship
- Tryptophan depletion in depressed patients occurs independent of kynurenine pathway activation
- (2012) Martina M. Hughes et al. BRAIN BEHAVIOR AND IMMUNITY
- Psychological stress and melanoma: Are we meeting our patients' psychological needs?
- (2012) Nadine Angele Kasparian CLINICS IN DERMATOLOGY
- Kynurenines: from the perspective of major psychiatric disorders
- (2012) Aye M. Myint FEBS Journal
- Hepatitis C infection, antiviral treatment and mental health: A European expert consensus statement
- (2012) Martin Schaefer et al. JOURNAL OF HEPATOLOGY
- Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase
- (2012) L. Pilotte et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immune changes and neurotransmitters: Possible interactions in depression?
- (2012) Barbara Sperner-Unterweger et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Evaluation of Current Cancer Immunotherapy
- (2011) Christopher S. Hourigan et al. CANCER JOURNAL
- Indoleamine 2,3-Dioxygenase Expression in Human Cancers: Clinical and Immunologic Perspectives
- (2011) J. Godin-Ethier et al. CLINICAL CANCER RESEARCH
- Serum Tryptophan and Kynurenine Concentrations as Parameters for Indoleamine 2,3-Dioxygenase Activity in Patients With Endometrial, Ovarian, and Vulvar Cancer
- (2011) Renske A. de Jong et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies
- (2011) Alex J Mitchell et al. LANCET ONCOLOGY
- Expression and prognostic impact of indoleamine 2,3-dioxygenase in oral squamous cell carcinomas
- (2011) Klaus Laimer et al. ORAL ONCOLOGY
- Immune system to brain signaling: Neuropsychopharmacological implications
- (2011) Lucile Capuron et al. PHARMACOLOGY & THERAPEUTICS
- Immunity, Inflammation, and Cancer
- (2010) Sergei I. Grivennikov et al. CELL
- Association between increased tryptophan degradation and depression in cancer patients
- (2010) Katharina Kurz et al. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- The PD-1 pathway in tolerance and autoimmunity
- (2010) Loise M. Francisco et al. IMMUNOLOGICAL REVIEWS
- Peripheral tumors induce depressive-like behaviors and cytokine production and alter hypothalamic-pituitary-adrenal axis regulation
- (2009) L. M. Pyter et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A High-Resolution Structure of the Pre-microRNA Nuclear Export Machinery
- (2009) C. Okada et al. SCIENCE
- High expression of indoleamine 2,3-dioxygenase gene in prostate cancer
- (2008) Chantal Feder-Mengus et al. EUROPEAN JOURNAL OF CANCER
- Neuroendocrine-Immune Mechanisms of Behavioral Comorbidities in Patients With Cancer
- (2008) Andrew H. Miller et al. JOURNAL OF CLINICAL ONCOLOGY
- Fluoxetine affords robust neuroprotection in the postischemic brain via its anti-inflammatory effect
- (2008) Chae-Moon Lim et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice
- (2008) J C O'Connor et al. MOLECULAR PSYCHIATRY
- Neurotoxic and neuroprotective metabolites of kynurenine in patients with renal cell carcinoma treated with interferon-α: Course and relationship with psychiatric status
- (2008) Arthur R. Van Gool et al. PSYCHIATRY AND CLINICAL NEUROSCIENCES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now